Dynavax Technologies, Kala Pharmaceuticals and TherapeuticsMD are three names this biotech investor plans to add exposure to via covered calls.
PFE reported Q1 earnings Tuesday and handily beat expectations.
Shares of Cara Therapeutics, Adverum Biotechnologies and Ardelyx Inc. all took big hits after each company announced unfavorable developments.
Here are our price targets for now.
UTHR and many other companies in this space are showing good strength; here's what the charts tell us.
The diverse names worth tracking are Riot Blockchain, Seagen Inc. and VanEck Vectors Semiconductor ETF.
This simple option strategy, which I continue to use with small-cap biotechs, is one of the easiest and cheapest risk mitigation approaches an individual can take.
Biotech stocks as a group have struggled in recent weeks; here's a strategy for mitigating risk when investing in these names.
Don't sit around waiting for headlines to confirm that fact.
Large purchases of Cortexyme Inc. and NantHealth Inc. shares have been made by insiders recently.